Lataa...
Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
The mechanisms underlying the resistance to immune checkpoint inhibitors (ICIs) therapy in metastatic urothelial carcinoma (mUC) patients are not clear. It is of great significance to discern mUC patients who could benefit from ICI therapy in clinical practice. In this study, we performed machine le...
Tallennettuna:
| Julkaisussa: | Front Immunol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7477044/ https://ncbi.nlm.nih.gov/pubmed/32983112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01900 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|